✦ LIBER ✦

Current Alzheimer's disease clinical trials: Methods and placebo outcomes

✍ Scribed by Lon S. Schneider; Mary Sano

Book ID: 118465698
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 220 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.07.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of placebo responses in Alzhe

Comparison of placebo responses in Alzheimer's disease clinical trials

✍ Ito, Kaori; Li, David; Corrigan, Brian 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Neuroimaging outcomes in clinical trials

Neuroimaging outcomes in clinical trials in Alzheimer’s disease

✍ Giovanni B. Frisoni; A. Delacourte 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 112 KB

Alzheimer's disease biomarkers as outcom

Alzheimer's disease biomarkers as outcome measures for clinical trials

✍ Caroli, Anna; Prestia, Annapaola; Wade, Sara; Chen, Kewei; Ayutyanont, Napatkamo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Imaging Outcomes for Clinical Trials In

Imaging Outcomes for Clinical Trials In Different Stages of Alzheimer's Disease

✍ Vernooij, Meike 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Alzheimer's disease: clinical trials and

Alzheimer's disease: clinical trials and drug development

✍ Francesca Mangialasche; Alina Solomon; Bengt Winblad; Patrizia Mecocci; Miia Kiv 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 230 KB

Alzheimer's disease: clinical trials and

Alzheimer's disease: clinical trials and drug development

✍ Francesca Mangialasche; Alina Solomon; Bengt Winblad; Patrizia Mecocci; Miia Kiv 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 230 KB

Alzheimer's disease is the most common cause of dementia in elderly people. Research into Alzheimer's disease therapy has been at least partly successful in terms of developing symptomatic treatments, but has also had several failures in terms of developing disease-modifying therapies. These success